Equipmake Holdings - Board Changes & Appointment of new CFO
22/04/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240422:nRSV4077La&default-theme=true
RNS Number : 4077L Equipmake Holdings PLC 22 April 2024
22 April 2024
Equipmake Holdings plc
("Equipmake" or the "Company")
Board Changes & Appointment of new Chief Financial Officer
Equipmake, the UK-based engineering specialist pioneering the development and
production of electrification products across the automotive, aerospace, bus,
and coach industries, is pleased to announce the appointment of Anthony
(Tony) Ratcliffe as Chief Financial Officer, Director, and Company Secretary,
with effect from 22 April 2024.
Tony will be based at the Group's U.K. headquarters and will work across its
international operations, to further strengthen the team as it rolls out its
global expansion plans, targeting key electrification markets. He will take
over from Steven McGillivray, who is stepping down from his position as CFO,
Director and Company Secretary with immediate effect, and who will provide
support over the coming six months. The Board would like to offer its
sincere thanks to Steven for his contribution to the Company in a period of
significant growth and change, including supporting the Company's IPO on Aquis
in 2022 and its recent fundraising. It wishes him the best for the next stage
of his career.
Tony has extensive senior financial experience gained in a number of ambitious
high growth technology companies on public markets, including both AIM and
Nasdaq. This experience extends across a number of sectors, including
healthcare, software and materials science. Most recently, as CFO of SourceBio
International, he contributed to a fourfold increase in revenues over a
two-year period, whilst significantly strengthening the balance sheet and
leading its AIM IPO, raising £35m, followed by the subsequent delisting and
sale of one of its three business units.
In prior CFO roles, Tony has acquired varied operational, transactional, and
strategic experience and driven significant growth, both organically and via
M&A, with an ultimate focus on creating value for shareholders.
Ian Foley, CEO of Equipmake, commented: "I am delighted to announce Tony's
appointment as Chief Financial Officer. He brings over two decades of
experience in fast growing international companies. Tony also has a wealth of
experience working within publicly listed companies and provides a valuable
additional perspective as Equipmake pursues its future opportunities and
business growth.
"Combined with the recent appointment of Nick Moelders as Chief Operating
Officer, Tony's appointment further strengthens our Board as we grow our
market presence and increase our impact as a rapidly scaling, global
electrification technology company, with a growing roster of customers.
"I would also like to use this opportunity to thank Steve for his dedication
and service to Equipmake over the last three years. Steve has helped to steer
Equipmake through what has been a transformational period for the Company. I
would like to wish him the very best in the future."
Disclosures required pursuant to Rule 4.9 of the Aquis Growth Market Apex
Rulebook
Tony Ratcliffe has the following current and previous directorships, over the
last five years, to declare. He does not hold any securities issued by the
Company.
Current directorships Former directorships, within the last five years
Consilium Financial Limited SourceBio International Limited (formerly SourceBio International plc)
Source BioScience Inc
Source BioScience Ireland Limited
Source BioScience (Storage) Limited
Source Bioscience UK Limited
Source BioScience (Healthcare) Limited
Select Pharma Laboratories Limited
Source BioScience (Orchard Place) Limited
Source BioScience (Cryobank) Limited
Geneservice Limited
Fairfield Imaging Limited
Fairfield Telepathology Limited
Kinetic Imaging Limited
Cryobank Guarantor Limited
Source BioScience Scotland Limited
LDPath Limited
SourceBio International Inc
Source Genomics Limited
Metalysis Limited*
High Entropy Alloys Limited
Metalysis High Entropy Alloys Limited
Metalysis Malaysia Sdn Bhd
Metalysis Titanium Limited
*Tony was, until 1 March 2020, a director of Metalysis Limited, which was put
into administration on 3 June 2019. Following the sale of assets, the process
of administration was subsequently completed on 9 June 2021, with unsatisfied
creditors amounting to c.£5m.
Save as set out in this announcement, Tony Ratcliffe has confirmed there are
no further details to be disclosed in connection with his appointment as a
director of the Company pursuant to Rule 4.9 of the Aquis Growth Market Apex
Rulebook.
For further information, please contact:
Equipmake Via St Brides Partners
Ian Foley, Founder and CEO
Panmure Gordon (Corporate Adviser & Joint Broker) Tel: +44 (0) 20 7886 2500
James Sinclair-Ford / Freddie Twist / Joseph Tan
Hugh Rich / Sam Elder
VSA Capital Limited (Joint Broker) Tel: +44 (0) 20 3005 5000
Simon Barton / Simba Khatai / Alex Cabral
St Brides Partners (Financial PR Adviser) Tel: +44 (0) 20 7236 1177
equipmake@stbridespartners.co.uk
Susie Geliher / Paul Dulieu
About Equipmake
Equipmake is the UK-based engineering specialist pioneering the development
and production of electrification products to meet the needs of the
automotive, aerospace and other sectors in support of the transition from
conventional fossil-fuelled to zero-emission powertrains.
Equipmake produces ultra-high performance electric motors and complete EV
drivetrains and ultra-fast power electronic systems. As well as developing
proprietary technology - such as an ultra-compact, lightweight high
performance spoke motor - it also offers bespoke R&D solutions.
Equipmake has developed a vertically integrated solution providing fully
bespoke solutions. The Company has built a significant pipeline of
opportunities, as demand for electric vehicles increases as part of the global
decarbonisation movement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NEXBRGDSGXBDGSC